ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
AB Corporate Bond ETF

AB Corporate Bond ETF (EYEG)

35.48
0.00
(0.00%)
At close: December 27 4:00PM
35.58
0.00
( 0.00% )
After Hours: 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
35.58
Bid
32.56
Ask
44.33
Volume
-
35.58 Day's Range 35.58
34.52 52 Week Range 37.24
Market Cap
Previous Close
35.48
Open
35.58
Last Trade
100
@
35.445
Last Trade Time
16:00:00
Financial Volume
-
VWAP
-
Average Volume (3m)
3,015
Shares Outstanding
7,689,000
Dividend Yield
-
PE Ratio
-1.94
Earnings Per Share (EPS)
-1.7
Revenue
-
Net Profit
-13.05M

About AB Corporate Bond ETF

The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers m... The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest. The Funds investment objective is to maximize total return through current income and longterm capital appreciation. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
AB Corporate Bond ETF is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEG. The last closing price for AB Corporate Bond ETF was $35.48. Over the last year, AB Corporate Bond ETF shares have traded in a share price range of $ 34.52 to $ 37.24.

AB Corporate Bond ETF currently has 7,689,000 shares outstanding. The market capitalization of AB Corporate Bond ETF is $272.81 million. AB Corporate Bond ETF has a price to earnings ratio (PE ratio) of -1.94.

EYEG Latest News

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st...

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended...

EyeGate Pharma Announces Positive Results in Second PRK Study

Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating...

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.130.36671368124135.4535.5835.37508135.47848118SP
4-0.7116-1.9607843137336.291636.4435.37805235.9597218SP
12-0.95-2.6006022447336.5336.5635.37301535.98487829SP
260.04410.12409985395135.535937.2435.0184185736.12599872SP
52-0.6622-1.8271517733536.242237.2434.52113135.93523856SP
1560.381.0795454545535.237.2434.52111535.93420688SP
2600.381.0795454545535.237.2434.52111535.93420688SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CCTGCCSC Technology International Holdings Ltd
$ 2.7599
(64.28%)
974.78k
AERTAeries Technology Inc
$ 1.19
(35.75%)
107.25k
BONBon Natural Life Ltd
$ 1.85
(8.82%)
20.3k
HEPAHepion Pharmaceuticals Inc
$ 0.50
(8.67%)
503
CARACara Therapeutics Inc
$ 0.388
(7.30%)
16.4k
MGIHMillennium Group International Holdings Ltd
$ 2.30
(-9.45%)
2.1k
PMAXPowell Max Ltd
$ 2.05
(-5.96%)
103
SYTASiyata Mobile Inc
$ 6.3431
(-5.87%)
805
FTCIFTC Solar Inc
$ 5.00
(-5.84%)
8.99k
FBYDFalcons Beyond Global Inc
$ 7.65
(-5.51%)
275
CMCSAComcast Corporation
$ 37.7881
(-0.41%)
1.41M
INTZIntrusion Inc
$ 2.19
(1.06%)
1.05M
CCTGCCSC Technology International Holdings Ltd
$ 2.7599
(64.28%)
974.78k
HOLOMicroCloud Hologram Inc
$ 2.5101
(5.03%)
622.33k
NVDANVIDIA Corporation
$ 137.14
(-0.01%)
591.34k

Discussion

View Full Feed
infamous infamous 4 minutes ago
oh it looks like they diluted yet ANOTHER 1mil to the OS. thank you Mark P
HWNI
georgie18 georgie18 4 minutes ago
Have a Great Weekend Y'all...🥳
Tr8dervic Tr8dervic 4 minutes ago
Our 12/27/24 MM #'s and No Play Deduction>

https://investorshub.advfn.com/uimage/uploads/2024/12/26/yqwlhMM12272024.jpg

** There are (( ** NO ** )) Deductions when I send out our Lottery Numbers **

* * Players that have ( 00 ) by their Name, are (( *
4retire 4retire 4 minutes ago
Checked X. Didn’t see anything remarkable
KULR
familyof5 familyof5 4 minutes ago
Clever one you are lol. You didn't answer my question but rather chose the path of diversion. Diversions aren't denials and more often than not are a admission of guilt. Be better than those you claim to have such disdain for TenKay.....
HMBL
WebSlinger WebSlinger 4 minutes ago
>

You didn't break anything down. You had AI create some BS response for you.
KBLB
georgie18 georgie18 4 minutes ago
Have a Great Weekend Y'all...🥳
Implanting Implanting 4 minutes ago
Who were the mystery voices explaining all the reasons to buy FMG, (but really make sure you do your own DD). They asked a lot of questions but didn't give many very solid answers. LOL We know the shares are undervalued, but why is that? Dilution was mentioned.

The huge thing they n
FFMGF
tw0122 tw0122 4 minutes ago
$17s 
MPLN
gitreal gitreal 5 minutes ago
everything the NEW CEO Jared stated, happened just as he said.

You believe the obvious lies about rhodium, Rich? This company claims to have ore with far higher rhodium than ever found, anywhere on earth. Not a red flag for you?

You really are one of the most gullibl
NBRI
rbl100 rbl100 5 minutes ago
Mr. Market (shorts) got their azz kicked LOL. Drug was approved by the FDA. Verify what I am saying. Go ahead.
FBIO
Huggy Bear Huggy Bear 5 minutes ago
NoMo loves to tell people the CD debt magically vanished, but it didn't.

It will be interesting to see if FINRA approves the reverse split request. At this junction they NEED it .
HMBL
Baylander1000 Baylander1000 5 minutes ago
Dude there are 1 B + shares and you bring up a fraction of shorts and a day to cover
ELTP
Clark6290 Clark6290 5 minutes ago
Very judgmental, I am a long term shareholder that is very optimistic. Please do not judge fellow human beings, very hurtful.

I do look forward to input from Along4zride, ne is never wrong
FNMA
WebSlinger WebSlinger 5 minutes ago
>

What a bunch of DEI BS....

What you are basically saying is that NOTHING is ever a failure....

What a crock....
KBLB
Iceman Iceman 5 minutes ago
IONQ had an awesome Xmas week!
IONQ made an all -time new high this week of $48.56!
IONQ closed 3 of the 4 days this week at the 3 highest closes ever of $44.58, $48.24, and $45.48 Today!

The charts love IONQ along with IONQ long investors.

IONQ loves
IONQ
maronti1 maronti1 6 minutes ago
Ty
VGTL
work-n-hard work-n-hard 6 minutes ago
ONDS: 2.47's now @ 2.73
ONDS
mick mick 6 minutes ago
coins

https://csnmint.com/44-years-of-mint-sets.html
JustJack JustJack 6 minutes ago
Wow, looks like another 92 million traded/diluted again.

Anyone think this ISN'T a share selling SCAM?
AITX
chrismiss_everyday chrismiss_everyday 7 minutes ago
https://finance.yahoo.com/news/karuna-krtx-48-14b-buyout-162000192.html

“Per the agreement terms, Bristol Myers will acquire all outstanding shares of Karuna for $330 per share in cash, aggregating to $14.0 billion.”

Blarcamesine…

https://www.anavex.com/t
AVXL
CaptBeer CaptBeer 7 minutes ago
This is a restricted label and is much narrower than the label in Spain or the UK for example. We'll have to see as time goes by if they will broden the label to be in line with other countries.
AMRN
laraz5 laraz5 7 minutes ago
EARI new O/S 3,143,500,050?

With 9B authorized a ways to go and a lot of shares to burn?


IMO
EARI
tw0122 tw0122 7 minutes ago
Round 2 
$2.40s 
INTZ